Results 221 to 230 of about 43,541 (256)

Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections [PDF]

, 2004
Joint United Nations Programme on HIV/AIDS, UNAIDS, World Health Organization, WHO   +1 more
core  

Injectable contraceptive continuation and user experiences in Punjab, Pakistan: a non-randomized prospective cohort study protocol. [PDF]

BMC Womens Health
Tappis H, Qayyum K, Bryce E, Fatima A, Christofield M, Haider H, Ameen A, Gardezi SMA, Rafay F, Assad F.   +9 more
europepmc   +1 more source

The Risk of GLP‐1 Receptor Agonist (GLP‐1 RA) Exposure in Early Pregnancy. A Call to Action: Quantifying the Impact on Pregnancy Outcomes in the United Kingdom

Diabetes, Obesity and Metabolism, EarlyView.
Michael Stedman, Pensee Wu, Ian Halsall, Nadia Chaudhury, Barbara McGowan, Martin B. Whyte, Akheel Syed, Adrian Heald   +7 more
wiley   +1 more source

Discontinuation, switching and contraceptive failure patterns of long-acting reversible contraceptive users in Kenya: a quantitative study. [PDF]

Sex Reprod Health Matters
de Almada M.
europepmc   +1 more source

Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials.

J Clin Endocrinol Metab
Efthymiadis A, Tsikopoulos K, Mills EG, Milne A, Dhillo WS, Abbara A, Comninos AN.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effect of exercise and oral contraceptive agents on fibrinolytic potential in trained females

Journal of Applied Physiology, 1984
It has been shown that physical exercise increases blood fibrinolytic potential, primarily by inducing a release of extrinsic plasminogen activator from the vessel wall. Synthetic estrogens have also been reported to influence fibrinolytic activity.
I A, Huisveld, C, Kluft, A J, Hospers, M J, Bernink, W B, Erich, B N, Bouma   +5 more
openaire   +2 more sources

Studies on aflatoxin B1 toxicity in female rats pretreated with an oral contraceptive agent

Food and Cosmetics Toxicology, 1976
The effect of oral administration of the contraceptive agent Ovral-28 (100 mcg/day) on the hepatotoxic effects of aflatoxin B1 was studied in female rats. The animals received Ovral-28 for 16 days prior to the ip administration of a single dose of aflatoxin B1.
M U, Mgbodile, M, Holscher
openaire   +2 more sources

Effect of aflatoxin B₁on hepatic drug-metabolizing enzymes in female rats. Interaction with a contraceptive agent

Xenobiotica, 1981
1. The effect of a contraceptive on aflatoxin B1 toxicity has been studied in female rats treated for 15 consecutive days with repeated doses of aflatoxin (0.40 mg/kg/day), norethindrone (0.60 mg/kg/day) and ethynylestradiol (0.012 mg/kg/day). 2. Increases occurred in hepatic microsomal cytochrome P-450 content (31%), and in the activities of epoxide ...
L, Kamdem, J, Magdalou, G, Siest
openaire   +2 more sources

Tissue distribution and pharmacokinetics of centchroman. A new nonsteroidal postcoital contraceptive agent and its 7-desmethyl metabolite in female rats after a single oral dose.

Drug Metabolism and Disposition, 1996
This study reports assay methodology, tissue distribution, and the basic pharmacokinetic behavior of centchroman and its 7-desmethyl metabolite [7-desmethyl centchroman (DMC)] after a single 12.5 mg/kg po dose in young female rats. Plasma, liver, lung, spleen, uterus, and adipose tissue were collected at various time intervals up to 14 days after dose.
J K, Paliwal, R C, Gupta
openaire   +2 more sources